<Disease><Name>2-HYDROXYGLUTARIC ACIDURIA (L)</Name><Synonym>2-HYDROXYGLUTARIC ACIDEMIA (L); L-2-HYDROXYGLUTARIC ACIDURIA; L2HGA</Synonym><OMIM><Number>236792</Number><URL>http://omim.org/entry/236792</URL></OMIM><Orphanet><Number>79314</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79314</URL></Orphanet><Protein><Number>L-2-hydroxyglutarate dehydrogenase, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/Q9H9P8</URL></Protein><ExPASy><Number>1.1.99.2</Number><URL>http://enzyme.expasy.org/EC/1.1.99.2</URL></ExPASy><Gene>14q21.3</Gene><ICD>E72.8</ICD><Summary>rare (&lt;1:1000000);autosomal recessive ;mutation in the L2HGDH gene;biochemical variants of 2-hydroxyglutaric aciduria: - L-2-hydroxyglutaric aciduria - D-2-hydroxyglutaric aciduria - combined D-2- and L-2-hydroxyglutaric aciduria</Summary><Symptoms><symtomp><id>4030</id><symptom>abnormalities (T) of the globus pallidus (MRI)</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2233</id><symptom>alopecia</symptom><category>SKIN | SKIN</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2363</id><symptom>basal ganglia, changes, lesions, calcifications (MRI, CT)</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1956</id><symptom>behavior, autism or autistic-like / behaviour, autism or autistic-like</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2117</id><symptom>CT, brain, abnormalities [-] / CT, kraniell, abnormal </symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1969</id><symptom>extrapyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2169</id><symptom>hyperpigmentation</symptom><category>SKIN</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3826</id><symptom>intellectual disability/intellectual developmental disorder</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1887</id><symptom>macrocephaly (large calvaria, &gt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1723</id><symptom>nystagmus</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1970</id><symptom>pyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1874</id><symptom>speech development, delayed, abnormal</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2173</id><symptom>strabismus</symptom><category>EYES</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1650</id><name>L-Lysine</name><specimen>urine</specimen><value /><min>3.70</min><max>51.30</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1954</id><name>L-Lysine</name><specimen>plasma</specimen><value>normal/inc</value><min>0.00</min><max>239.00</max><unit>&#956;mol/l</unit><age>Adulthood</age><method>HPLC</method><comment /></metabolite><metabolite><id>1955</id><name>L-Lysine</name><specimen>plasma</specimen><value>normal/inc</value><min>116.00</min><max>276.00</max><unit>&#956;mol/l</unit><age>Adolescence</age><method>HPLC</method><comment /></metabolite><metabolite><id>106</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1446</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>564</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>14.00</min><max>97.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>565</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>15.00</min><max>150.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>567</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>5.00</min><max>25.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>2135</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>50.00</max><unit>mmol/ml crea</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>331</id><name>2-Hydroxyglutaric acid (L)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit /><age>child</age><method /><comment /></metabolite><metabolite><id>336</id><name>2-Hydroxyglutaric acid (L)</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>1.00</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>566</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>7.50</min><max>36.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>715</id><name>2-Hydroxyglutaric acid (L)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>56.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>716</id><name>2-Hydroxyglutaric acid (L)</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>child</age><method /><comment /></metabolite><metabolite><id>717</id><name>2-Hydroxyglutaric acid (L)</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.30</min><max>2.30</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1916</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>56.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>1917</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>7.00</min><max>58.00</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>2029</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>26</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>10.00</min><max>69.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>471</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>22.00</min><max>171.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>876</id><name>L-Lysine</name><specimen>urine</specimen><value>increased</value><min>13.00</min><max>199.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method>HPLC</method><comment>fasted</comment></metabolite><metabolite><id>25</id><name>L-Lysine</name><specimen>plasma</specimen><value>normal/inc</value><min>92.00</min><max>325.00</max><unit>&#956;mol/l</unit><age>Neonatal</age><method>HPLC</method><comment /></metabolite><metabolite><id>41</id><name>L-Lysine</name><specimen>plasma</specimen><value>normal/inc</value><min>52.00</min><max>196.00</max><unit>&#956;mol/l</unit><age>Infancy</age><method>HPLC</method><comment /></metabolite><metabolite><id>42</id><name>L-Lysine</name><specimen>plasma</specimen><value>normal/inc</value><min>66.00</min><max>270.00</max><unit>&#956;mol/l</unit><age>Childhood</age><method>HPLC</method><comment /></metabolite><metabolite><id>335</id><name>L-Lysine</name><specimen>cerebrospinal fluid</specimen><value>normal/inc</value><min>10.00</min><max>25.00</max><unit>&#956;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>766</id><name>Protein, total</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>10.00</min><max>30.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6603</id><title>Oxidative stress among L-2-hydroxyglutaric aciduria disease patients: evaluation of dynamic thiol/disulfide homeostasis</title><author>Cansever MS,</author><journal>Metab Brain Dis</journal><year>2019</year><book /><volume>34</volume><number>1</number><pages>283-288</pages><co_aut>et al.</co_aut></literature><literature><id>6604</id><title>Two novel L2HGDH mutations identified in a rare Chinese family with L-2-hydroxyglutaric aciduria</title><author>Peng W,</author><journal>BMC Med Genet</journal><year>2018</year><book /><volume>19</volume><number>1</number><pages>167</pages><co_aut>et al.</co_aut></literature><literature><id>6605</id><title>A novel compound heterozygous mutation of the L2HGDH gene in a Chinese boy with L-2-hydroxyglutaric aciduria: case report and l</title><author>Zhang Y,</author><journal>Neurol Sci</journal><year>2018</year><book /><volume>39</volume><number>10</number><pages>1697-1703</pages><co_aut>et al.</co_aut></literature><literature><id>6628</id><title>Teaching NeuroImages: Imaging in metabolic leukoencephalopathy, L-2-hydroxyglutaric aciduria</title><author>Sivadasan S,</author><journal>Neurology</journal><year>2018</year><book /><volume>91</volume><number>16</number><pages>e1549-1550</pages><co_aut>S V, Sundaram S</co_aut></literature><literature><id>6652</id><title>Identification of novel L2HGDH mutation in a large consanguineous Pakistani family- a case report</title><author>Ullah MI,</author><journal>BMC Med Genet</journal><year>2018</year><book /><volume>19</volume><number>1</number><pages>25</pages><co_aut>et al.</co_aut></literature><literature><id>3332</id><title>Experimental evidence of oxidative stress in patients with l-2-hydroxyglutaric aciduria and that l-carnitine attenuates in vitr</title><author>Rodrigues DGB,</author><journal>Toxicol In Vitro</journal><year>2017</year><book /><volume>42</volume><number>0</number><pages>47-53</pages><co_aut>et al.</co_aut></literature><literature><id>3331</id><title>Inherited metabolic disorders in Turkish patients with autism spectrum disorders</title><author>Kiykim E,</author><journal>Autism Res</journal><year>2016</year><book /><volume>9</volume><number>2</number><pages>217-223</pages><co_aut>et al.</co_aut></literature><literature><id>3334</id><title>White matter abnormalities in an adult patient with l-2-hydroxyglutaric aciduria</title><author>Yamamoto T,</author><journal>Brain Dev</journal><year>2016</year><book /><volume>38</volume><number>1</number><pages>142-144</pages><co_aut>et al.</co_aut></literature><literature><id>5548</id><title>In-vivo brain H1-MR-Spectroscopy identification and quantification of 2-hydroxyglutarate in L-2-Hydroxyglutaric aciduria</title><author>Anghileri E,</author><journal>Brain Res</journal><year>2016</year><book /><volume>1648</volume><number>0</number><pages>506-5011</pages><co_aut>et al.</co_aut></literature><literature><id>3330</id><title>A novel compound heterozygous mutation in a Chinese boy with L-2-hydroxyglutaric aciduria: a case study</title><author>Tai H,</author><journal>BMC Neurol</journal><year>2015</year><book /><volume>25</volume><number>0</number><pages>117</pages><co_aut>Zhang Z</co_aut></literature><literature><id>3333</id><title>Gliomatosis cerebri in L-2-hydroxyglutaric aciduria</title><author>London F,</author><journal>Acta Neurol Belg</journal><year>2015</year><book /><volume>115</volume><number>4</number><pages>749-751</pages><co_aut>Jeanjean A</co_aut></literature><literature><id>3335</id><title>A mouse model of L-2-hydroxyglutaric aciduria, a disorder of metabolite repair</title><author>Rzem R,</author><journal>PLoS One</journal><year>2015</year><book /><volume>10</volume><number>3</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3336</id><title>Successive distinct high-grade gliomas in L-2-hydroxyglutaric aciduria</title><author>Patay Z,</author><journal>J Inherit Metab Dis</journal><year>2015</year><book /><volume>38</volume><number>2</number><pages>273-277</pages><co_aut>et al.</co_aut></literature><literature><id>3337</id><title>An interesting case of metabolic dystonia: L-2 hydroxyglutaric aciduria</title><author>Balaji P,</author><journal>Ann Indian Acad Neurol</journal><year>2014</year><book /><volume>17</volume><number>1</number><pages>97-99</pages><co_aut>et al.</co_aut></literature><literature><id>3127</id><title>Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)</title><author>Horvath R</author><journal>J Inherit Metab Dis</journal><year>2012</year><book /><volume>35</volume><number>4</number><pages>679-687</pages><co_aut /></literature><literature><id>6611</id><title>An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study</title><author>Steenweg ME,</author><journal>Hum Mutat</journal><year>2010</year><book /><volume>31</volume><number>4</number><pages>380-390</pages><co_aut>et al.</co_aut></literature><literature><id>2798</id><title>Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria</title><author>Yilmaz K</author><journal>Eur J Paediatr Neurol</journal><year>2009</year><book /><volume>13</volume><number>1</number><pages>57-60</pages><co_aut /></literature><literature><id>2807</id><title>L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair</title><author>Van Schaftingen E,</author><journal>J Inher Metab Dis</journal><year>2009</year><book /><volume>32</volume><number>2</number><pages>135-142</pages><co_aut>Rzem R, Veiga-da-Cunha M</co_aut></literature><literature><id>2808</id><title>L-2-Hydroxyglutaric aciduria presenting with severe autistic features</title><author>Zafeiriou DI,</author><journal>Brain Dev</journal><year>2008</year><book /><volume>30</volume><number>4</number><pages>305-307</pages><co_aut>et al.</co_aut></literature><literature><id>2817</id><title>Sudden unexpected death in an infant with L-2-hydroxyglutaric aciduria</title><author>Jequier Gygax M,</author><journal>Eur J Pediatr</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2194</id><title>L-2-hydroxyglutaric aciduria: clinical, neuroimaging, and neuropathological findings</title><author>Seijo-Martinez M</author><journal>Arch Neurol</journal><year>2005</year><book /><volume>62</volume><number>4</number><pages>666-670</pages><co_aut>et al.</co_aut></literature><literature><id>2195</id><title>L-2-hydroxyglutaric aciduria: a report of 29 patients</title><author>Topcu M</author><journal>Turk J Pediatr</journal><year>2005</year><book /><volume>47</volume><number>1</number><pages>1-7</pages><co_aut>et al.</co_aut></literature><literature><id>2196</id><title>L-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1</title><author>Topcu M</author><journal>Hum Mol Genet</journal><year>2004</year><book /><volume>13</volume><number>22</number><pages>2803-2811</pages><co_aut>et al.</co_aut></literature><literature><id>2197</id><title>A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria</title><author>Rzem R</author><journal>Proc Natl Acad Sci U S A</journal><year>2004</year><book /><volume>101</volume><number>48</number><pages>16849-54</pages><co_aut>et al.</co_aut></literature><literature><id>1343</id><title>Single-voxel MR spectroscopy and diffusion-weighted MRI in two patients with l-2-hydroxyglutaric aciduria</title><author>Aydin K</author><journal>Pediatr Radiol</journal><year>2003</year><book /><volume>33</volume><number>0</number><pages>872-876</pages><co_aut>et al.</co_aut></literature><literature><id>1344</id><title>Disease-related metabolites in culture medium of fibroblasts from patients with D-2-hydroxyglutaric aciduria, L-2-hydroxyglutar</title><author>Struys EA</author><journal>Clin Chem</journal><year>2003</year><book /><volume>49</volume><number>7</number><pages>1133-1138</pages><co_aut>et al.</co_aut></literature><literature><id>1342</id><title>L-2-Hydroxyglutaric aciduria presenting as status epilepticus</title><author>Zafeiriou DI</author><journal>Brain Dev</journal><year>2001</year><book /><volume>23</volume><number>4</number><pages>255-257</pages><co_aut>et al.</co_aut></literature><literature><id>1347</id><title>Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglut</title><author>Muntau AC</author><journal>Neuropediatrics</journal><year>2000</year><book /><volume>31</volume><number>3</number><pages>137-140</pages><co_aut>et al.</co_aut></literature><literature><id>1515</id><title>Chiral liquid chromatography tandem mass spectrometry in the determination of the configuration of 2-hydroxyglutaric acid in ur</title><author>Rashed MS</author><journal>Biomed Chromatogr</journal><year>2000</year><book /><volume>14</volume><number>5</number><pages>317-320</pages><co_aut>AlAmoudi M, Aboul-Enein HY</co_aut></literature><literature><id>1348</id><title>L-2-hydroxyglutaric aciduria: two Japanese adult cases in one family</title><author>Fujitake J</author><journal>J Neurol</journal><year>1999</year><book /><volume>246</volume><number>5</number><pages>378-382</pages><co_aut>et al.</co_aut></literature><literature><id>963</id><title>L-2Hydroxyglutaric aciduria and lactic acidosis</title><author>Barth PG</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>0</number><pages>251-254</pages><co_aut>et al.</co_aut></literature><literature><id>770</id><title>L-2-hydroxyglutaric aciduria: normal L-2-hydroxyglutarate dehydrogenase activity in liver from two new patients</title><author>Wanders RJA</author><journal>J Inherit Metab Dis</journal><year>1997</year><book /><volume>20</volume><number>0</number><pages>725-726</pages><co_aut>et al</co_aut></literature><literature><id>747</id><title>Various organic acidurias</title><author>Jakobs C</author><journal>in Blau N, Duran M, Blaskovics E (eds): in Physicians guuide to the laboratory diagnosis of metabolic diseases; Chapman and Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>163-176</pages><co_aut>et al.</co_aut></literature><literature><id>752</id><title>L-2-hydroxyglutaric acidemia: clinical and biochemical findings in 12 patients and preliminary report on L-2-hydroxyacid dehydro</title><author>Barth PG</author><journal>J Inherit Metab Dis</journal><year>1993</year><book /><volume>16</volume><number>0</number><pages>753-761</pages><co_aut>et al.</co_aut></literature><literature><id>753</id><title>Stable isotope dilution analysis of D- and L-2-hydroxyglutaric acid: application to the detection and prenatal diagnosis od D- a</title><author>Gibson KM</author><journal>Pediatr Res</journal><year>1993</year><book /><volume>34</volume><number>0</number><pages>277-280</pages><co_aut>et al.</co_aut></literature><literature><id>22</id><title>L-2-Hydroxyglutaric acid Acidemia: A Novel Inherited Neurometabolic Disease</title><author>Barth PG</author><journal>Annals of Neurology</journal><year>1992</year><book /><volume>32</volume><number>1</number><pages>66-71</pages><co_aut>Hoffmann GF, Jaeken J, Lehnert W, Hanefeld F, van Gennip AH, Duran M, Valk J, Schutgens RBH, Trefz FK, Reimann G, Hartun</co_aut></literature></Literatures></Disease>